Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lux

Showing results (191-200 of 233) with videos related to

Pageof 24
Sort By:
Geburtshilfe Und Frauenheilkunde|May 31, 2024
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT RegistryAndreas D Hartkopf, Christina B Walter, Hans-Christian Kolberg, et al.
Geburtshilfe Und Frauenheilkunde|August 29, 2017
Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer RegistryMarkus Wallwiener, Felix Heindl, Sara Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde|May 19, 2025
Update Breast Cancer 2024 Part 3 - Patients with Advanced Stage Breast CancerDiana Lüftner, Hans-Christian Kolberg, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde|November 2, 2023
Update Breast Cancer 2023 Part 1 - Early Stage Breast CancerAndreas D Hartkopf, Tanja N Fehm, Manfred Welslau, et al.
Geburtshilfe Und Frauenheilkunde|November 2, 2023
Update Breast Cancer 2023 Part 2 - Advanced-Stage Breast CancerMichael P Lux, Andreas D Hartkopf, Tanja N Fehm, et al.
Geburtshilfe Und Frauenheilkunde|September 14, 2023
Update Breast Cancer 2023 Part 3 - Expert Opinions of Early Stage Breast Cancer TherapiesHans-Christian Kolberg, Andreas D Hartkopf, Tanja N Fehm, et al.
Cancers|October 21, 2020
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with PertuzumabLaura L Michel, Andreas D Hartkopf, Peter A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|December 2, 2020
Correction: Treatment Landscape and Prognosis After Treatment with Trastuzumab EmtansineElena Laakmann, Julius Emons, Florin-Andrei Taran, et al.
Cancers|December 23, 2018
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer RegistryMichael P Lux, Naiba Nabieva, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde|May 19, 2025
Update Breast Cancer 2024 Part 2 - Patients with Early Stage Breast CancerWolfgang Janni, Hans-Christian Kolberg, Andreas D Hartkopf, et al.
Pageof 24

Showing results (191-200 of 233) with videos related to

Sort By:
Pageof 24
Geburtshilfe Und Frauenheilkunde|May 31, 2024
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT RegistryAndreas D Hartkopf, Christina B Walter, Hans-Christian Kolberg, et al.
Geburtshilfe Und Frauenheilkunde|August 29, 2017
Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer RegistryMarkus Wallwiener, Felix Heindl, Sara Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde|May 19, 2025
Update Breast Cancer 2024 Part 3 - Patients with Advanced Stage Breast CancerDiana Lüftner, Hans-Christian Kolberg, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde|November 2, 2023
Update Breast Cancer 2023 Part 1 - Early Stage Breast CancerAndreas D Hartkopf, Tanja N Fehm, Manfred Welslau, et al.
Geburtshilfe Und Frauenheilkunde|November 2, 2023
Update Breast Cancer 2023 Part 2 - Advanced-Stage Breast CancerMichael P Lux, Andreas D Hartkopf, Tanja N Fehm, et al.
Geburtshilfe Und Frauenheilkunde|September 14, 2023
Update Breast Cancer 2023 Part 3 - Expert Opinions of Early Stage Breast Cancer TherapiesHans-Christian Kolberg, Andreas D Hartkopf, Tanja N Fehm, et al.
Cancers|October 21, 2020
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with PertuzumabLaura L Michel, Andreas D Hartkopf, Peter A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|December 2, 2020
Correction: Treatment Landscape and Prognosis After Treatment with Trastuzumab EmtansineElena Laakmann, Julius Emons, Florin-Andrei Taran, et al.
Cancers|December 23, 2018
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer RegistryMichael P Lux, Naiba Nabieva, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde|May 19, 2025
Update Breast Cancer 2024 Part 2 - Patients with Early Stage Breast CancerWolfgang Janni, Hans-Christian Kolberg, Andreas D Hartkopf, et al.
Pageof 24